Shionogi Covid Pill May Get China Approval In March: Ceo

Shionogi Covid Pill May Get China Approval in March: CEO

Bloomberg Television

Japan's Shionogi Says Its Covid Pill's Sales May Hit $2 Billion

Bloomberg Television

Japanese COVID 19 pill wins emergency approval

Nippon TV News 24 Japan

China-based biopharmaceutical firm says its Covid drug causes fewer side effects than Paxlovid

CNBC International News

SHIONOGI COVID 19 PILL IN JAPAN FOR QUICK APPROVAL

#China Grants Conditional Approval for 2 Domestically Developed #Covid 19 Drugs #fyp #medicine #smal

International Channel Shanghai

Shionogi COVID Pill "Rapid Clearance" of Coronavirus, Company Says

Dating Coach Ella

China Approves Inhaled Covid Vaccine

Bloomberg Television

WHO approves China’s CanSino COVID-19 vaccine for emergency use

Shanghai Henlius Biotech Working on Covid Treatment Drug

Bloomberg Television

China's homegrown COVID-19 drugs expected for delivery within month after conditional approval

ShanghaiEye魔都眼

China 'Definitely' Needs 2nd Covid Booster Dose: CanSino Biologics CEO

Bloomberg Television

Pharmacologic Data on New and Pipeline Drugs - Shionogi Inc. | Simon Portsmouth

Academic Medical Education

Japanese drug maker's COVID 19 pills effective against Omicron

Nippon TV News 24 Japan

Chinese biopharma firm Everest Medicines is testing an mRNA Covid-19 vaccine

CNBC International News

BeiGene CEO on Coronavirus Impact, China Biopharma, Product Pipeline

Bloomberg Television

China gives conditional approval to COVID-19 vaccine

Shionogi & Co (4507 JP): Ready To Cash-In On COVID-Related Efforts; Long-Term Growth Drivers Added

Japanese pharmaceutical company starts final phase of clinical trial for COVID 19 oral drug

Nippon TV News 24 Japan

Passengers from China to take a covid test before being allowed into Canada.